AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01654289 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation
Description: Training will consist of a standardized 8-week Mindfulness Based Stress Reduction (MBSR) program, including 2½ hour weekly sessions and regular at-home daily practice. Didactic sessions center on awareness of physical, emotional, cognitive, and interpersonal responses to stress. A half day meditation retreat on a weekend day at the end of week 6 will allow participants to practice their skills.
Study NCT01654289 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Exercise training will primarily focus on walking or jogging, activities that are convenient, easy to teach and do not require special equipment. Individualized programs will be developed for those who have access to specific equipment, are unable to do walking/jogging, or prefer different types of exercise. Each weekly exercise session will include 1½ hours of didactic and 1 hour of group exercise. A half day exercise retreat designed to match the meditation retreat will occur the weekend of week 6. The retreat will include didactics, group discussion and activities, and individualized exercise practice.
Study NCT02274350 — intervention group
Intervention type: RADIATION
Intervention: radiation therapy
Description: Radiation therapy either in the form of external beam radiation or radioactive gold seeds planted directly in the prostate.
Study NCT02388399 — intervention group
Intervention type: PROCEDURE
Intervention: Device
Description: Optical coherence tomography to evaluate plaque morphology and vulnerable features (ex> cap thickness, spotty calcification)
Study NCT02388399 — intervention group
Intervention type: PROCEDURE
Intervention: Device
Description: Resting and hyperemic pressure pullback tracing will be done with motorized pullback system.
Study NCT01403805 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccination (Pneumovax NP, 21800AMY10131000)
Description: Injection,subcutaneous,0.5ml,ones,Planned duration of intervention:a day
Study NCT01403805 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza vaccination (Flubik HA, 16100EZZ01207000)
Description: Injection,subcutaneous,0.5ml,ones,Planned duration of intervention:a day
Study NCT03271190 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ENGAGE SPANISH/MUSIC
Description: Cognitive strategies to improve attention and memory skills (21 hours), leisure activities (music lessons or Spanish lessons) (27 hours), selected videogames to practice variable attention strategies (4 hours in class + about 10 hours at home). Total of 24 2-hour in class sessions over 4 months. The training will be delivered to small groups of 5 to 8 participants by a trained therapist for formal sessions and a professional music or Spanish teacher for leisure sessions.
Study NCT03271190 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ENGAGE DISCOVERY
Description: Educational content about brain and healthy aging (21 hours), leisure activities (watching documentaries followed by group discussion and debate) (27 hours), selected non-stimulating videogames (4 hours in class + about 10 hours at home). Total of 24 2-hour in class sessions over 4 months. The training will be delivered to small groups of 5 to 8 participants by the same trained therapist as in the ENGAGE arm.
Study NCT01403805 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Influenza vaccination (Flubik HA, 16100EZZ01207000)
Description: Injection,subcutaneous,0.5ml,ones,Planned duration of intervention:a day
Study NCT01403805 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Specific frequency of oral care
Description: 1 dentist and 2 dental hygienists visited the nursing home once a week. After the residents agreed our receive oral care, the dentist/dental hygienist spent 15 minutes with brushing of teeth, scaling, oral wiping, gargling and cleaning of dentures, to reduce dental plaque which is oral bacteria mechanically by using cleaning tools, including toothbrush, interdental brush, dental scaler, tongue brush, and sponge brush to treatment of periodontal disease at the washstand in their private room primary care physicians. At the same time, they taught and recorded to the nursing care workers the methods of administering responsible oral care to dye for dental plaque by using plaque disclosing agent material.
Study NCT01699802 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inhaled anaesthetic agent
Study NCT02243488 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Irise Easy Pad & Menstrual Health Education
Description: Reusable manufactured sanitary pad produced by Irise Uganda Limited and education sessions provided by qualified menstrual health educators
Study NCT04554901 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Cocoa
Description: 2-week, once-daily 70%, 50g cocoa bar manufactured by The UWI Cocoa Research Institute (14 bars)
Study NCT03271528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacosamide
Description: Lacosamide titration was done to a target dose of 300mg. Participants took 100 mg of lacosamide once on day 1, 100 mg twice per day from day 2 through day 6 (200 mg daily total), on day 7 the lacosamide dose was increased to 150 mg twice daily (300 mg daily total), and on day 8 the participant took one dose of 150 mg.
Study NCT03271528 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsule
Description: Participants took a placebo oral capsule once on day 1, twice per day from day 2 to day 7, and once on day 8.
Study NCT00621686 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: bevacizumab
Study NCT00621686 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sorafenib tosylate
Study NCT03943342 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: Given PO
Study NCT03943342 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO
Study NCT01592799 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Throat swab and/or nasopharyngeal swab
Description: Samples will be tested to quantify the inpatient and ER visits burden of laboratory-confirmed influenza.
Study NCT01592799 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Data collection
Description: Log Sheet will be used to collected data on a monthly basis for the following age groups: \< 6 months; 6-23 months; 24-59 months; > 5 years.
Study NCT02081261 — intervention group
Intervention type: PROCEDURE
Intervention: Coronary artery bypass surgery
Description: coronary artery bypass surgery
Study NCT02058628 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clindamycin + BPO
Description: Gel containing 1.2% clindamycin and 3% BPO for once daily application
Study NCT02058628 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azelaic acid
Description: Cream containing 20% azelaic acid for twice daily application
Study NCT01790620 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CVVHD
Description: CVVHD will be used during 72 hours with a prescribed dose of 30 ml/Kg/h Prismasol® 4 as dialysate fluid. Blood flow of 200-250 ml/min, to achieve 12 - 15 L/h will be prescribed. Isovolemic CRRT will be encouraged during this 72 hours if volume overload status is not present. After 72 hours, CVVHD will be continued and dialysate dose (ml/kg/h) will be adjusted to achieve creatinine levels between 80-120 umol/L until patient recovers urine output and / or tolerates intermittent hemodialysis.
Study NCT01790620 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CVVH
Description: CVVH will be used during 72 hours with a prescribed dose of 30 ml/Kg/h Prismasol® 4 as reposition fluid. Blood flow of 200-250 ml/min, to achieve 12 - 15 L/h will be prescribed adjusting the adequate percentage of prefilter reinfusion to maintain a theorical filtration fraction between 18-22%. Isovolemic CRRT will be encouraged if volume overload status is not present. After 72 hours, CVVH will be continued and filtration dose (ml/kg/h) will be adjusted to achieve creatinine levels between 80-120 umol/L until patient recovers urine output and / or tolerates intermittent hemodialysis.
Study NCT01218087 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cranial cup device and Moldable positioner
Description: The cranial cup device was used 12/24 hours (alternating with the moldable positioner device) and was evaluated for feasibility, safety and efficacy for preventing head shape deformity in hospitalized infants
Study NCT01218087 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Moldable positioner device
Description: This moldable positioning device was used 24/24 hours as a comparison to the cranial cup device.
Study NCT01218087 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Moldable positioner device
Description: This moldable positioning device was used 24/24 hours as a comparison to the cranial cup device.
Study NCT02604992 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A
Description: Dronabinol oral solution, under fed conditions
Study NCT02604992 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B
Description: Dronabinol oral capsule, under fed conditions
Study NCT02604992 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C
Description: Dronabinol oral capsule, under fasted conditions
Study NCT04714879 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Device: anodal tDCS
Description: anodal current modulated by an oscillatory component including a fixed (0,75 Hz) versus individually adapted so-tDCS frequency with three different stimulation durations (5 min, 2 min, 30 sec)
Study NCT04714879 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Device: no stimulation
Description: sham stimulation
Study NCT03285516 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Safety Aid Reduction Treatment
Description: START includes many of the key elements found in empirically supported treatments for emotional disorders including a) psychoeducation regarding the nature of distress and b) exposure to internal sensations and external situations that are connected to one's distress response via identification and reduction in safety aids. Safety aids discussed in the current protocol include cognitive avoidance, situational avoidance, checking behaviors, reassurance seeking, avoidance of bodily sensations, companions, and use of alcohol and other substances.
Study NCT01139125 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (Cystagon) Cysteamine Bitartrate
Description: Cysteamine Bitartrate 300mg/day to 2100mg/day over a 4 month period. Number of cycles: until progression or unacceptable toxicity develops.
Study NCT02547428 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CTN SR
Description: CTN SR tablets, daily, Orally.
Study NCT06182631 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A band will be placed on the arm before IV insertion for placebo effect.
Study NCT04302727 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Med-South Weight Loss Intervention
Description: Phase I is a 4-month lifestyle program focused on the basics of healthy eating. Phase II (8 months) focuses on weight loss, followed by a year-long (Phase III) focused on weight loss maintenance. In Phase I, the main counseling sessions happen at monthly visits, with added check-in phone calls. In Phase II, the main counseling sessions will occur weekly for 6-8 weeks. There are also check-in phone calls - number based on weight loss progress. During Phase III, there are 2 main visits and follow-up phone calls. Counseling visits will be in-person with a health counselor and by phone. Of the 14 core counseling sessions, the in-person format will be required for only 4 (the 1st session of each Phase and after 2 months of the weight loss program). The program also includes brief phone calls to check on progress towards goals for lifestyle change. The number of phone calls will depend on success in meeting personal weight loss goals in Phase II or keeping the weight off in Phase III.
Study NCT04302727 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: WW
Description: If participants are randomized to WW™, they will have access to both the workshop and digital components of the WW™ program for 2 years. The workshop component includes the option of attending weekly group meeting at a WW™ studio (local WW™ office). The digital component can be accessed using the WW™ website or the smart phone App. The study research staff will provide basic instructions on how to use the WW™ digital resources.
Study NCT02547428 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching placebo
Description: Matching-placebo tablets daily, orally.
Study NCT03288545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: enfortumab vedotin (EV)
Description: Intravenous (IV) infusion on days 1 and 8 every 21 days
Study NCT03288545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pembrolizumab
Description: IV infusion on day 1 every 21 days
Study NCT03288545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Description: IV infusion on day 1 every 21 days
Study NCT03288545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: IV infusion on day 1 every 21 days
Study NCT03288545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine
Description: IV infusion on days 1 and 8 every 21 days
Study NCT02356939 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: intraductal removable stent custom-made segment (2 cm)
Description: : In the IST group, the surgeon will place the IST in the bile duct, which is a custom-made segment (2 cm) of a 8 French T-tube. The stent is inserted in the biliary duct without suture fixation.~In order to minimize bias and to homogenize the technique, a short technical explanatory movie was realized by the promoter's team and edited on internet.~In the IST group, an endoscopic retrograde cholangio-pancreatography (ERCP) with sphincterotomy will be planned between the 4th and the 5th month post-transplantation, requiring a short stay in hospital, a general anesthesia, clinical and biological tests including plasmatic lipase dosage at Day 1.
Study NCT02356939 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: stent extraction by ERCP
Description: stent extraction by endoscopic retrograde cholangio-pancreatography
Study NCT01663961 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YM178 OCAS
Description: oral
Study NCT01663961 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Digoxin
Description: oral
Study NCT02250911 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: webcasts
Study NCT02250911 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Assessments
Study NCT02250911 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Assessments
Study NCT00806897 — intervention group
Intervention type: DRUG
Intervention: insulin detemir
Description: Effectiveness data collection in connection with the use of the drug Levemir® in daily clinical practice.
Study NCT03526250 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT03526250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Given PO
Study NCT02250911 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Study NCT01695993 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Acupressure bands
Description: Bilateral acupressure wrist bands
Study NCT01695993 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupressure bands
Description: Bilateral acupressure wrist bands
Study NCT04335851 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video based aerobic exercise
Description: During social isolation induced by COVID-19, physically inactive people will do exercise in company with aerobic exercises named videoswalk at home which made by American Heart Association. 3 days a week in total 4 weeks. Each sessions will last approximately 30-40 minutes.
Study NCT01695993 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Expectancy-neutral handout
Description: The expectancy neutral handout has neutral information regarding the acupressure bands
Study NCT01760031 — intervention group
Intervention type: OTHER
Intervention: Ischemic preconditioning
Description: Subjects received ischemic preconditioning previous to cardiac catheterization
Study NCT03153904 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, and Conduct Problems
Description: MATCH-ADTC (Chorpita \& Weisz, 2009) is designed for children aged 6-15. Unlike most evidence-based treatments (EBTs), which focus on single disorder categories (e.g., anxiety only), MATCH is designed for multiple disorders and problems encompassing anxiety, depression, post-traumatic stress, and disruptive conduct, including the conduct problems associated with ADHD. MATCH is composed of 33 modules-i.e., specific treatment procedures derived from decades of research on EBTs. The various modules can be organized and sequenced flexibly to tailor treatment to each child's characteristics and needs.
Study NCT01695993 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Expectancy-neutral MP3
Description: Patients will be given a portable MP3 player and relaxation MP3 that is about 12 minutes in length with a flute music background and guided imagery.
Study NCT03153904 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, and Conduct Problems
Description: MATCH-ADTC (Chorpita \& Weisz, 2009) is designed for children aged 6-15. Unlike most evidence-based treatments (EBTs), which focus on single disorder categories (e.g., anxiety only), MATCH is designed for multiple disorders and problems encompassing anxiety, depression, post-traumatic stress, and disruptive conduct, including the conduct problems associated with ADHD. MATCH is composed of 33 modules-i.e., specific treatment procedures derived from decades of research on EBTs. The various modules can be organized and sequenced flexibly to tailor treatment to each child's characteristics and needs.
Study NCT03153904 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Monitoring and Feedback System
Description: For each child, the web-based MFS provides weekly monitoring of the MATCH modules used and the child's treatment response, in two forms (a) changes on the Brief Problem Monitor (BPM) and (b) changes in severity of the top treatment concerns identified by youths and caregivers. At the end of treatment, the MFS provides a complete record of modules used, and child treatment response, across all weeks of treatment.
Study NCT03153904 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Monitoring and Feedback System
Description: For each child, the web-based MFS provides weekly monitoring of the MATCH modules used and the child's treatment response, in two forms (a) changes on the Brief Problem Monitor (BPM) and (b) changes in severity of the top treatment concerns identified by youths and caregivers. At the end of treatment, the MFS provides a complete record of modules used, and child treatment response, across all weeks of treatment.
Study NCT02915770 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cholangiojejunostomy
Description: Half of participants will receive hepatectomy, cholangiojejunostomy and T-tube Drainage,while the other half will receive hepatectomy and T-tube Drainage
Study NCT02915770 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: hepatectomy
Study NCT02915770 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: hepatectomy
Study NCT02915770 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: T-tube
Description: T-tube Drainage
Study NCT02915770 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: T-tube
Description: T-tube Drainage
Study NCT02898597 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Description: Received 8 weekly individualized counseling sessions of cognitive behavioral therapy
Study NCT02898597 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioral Therapy
Description: Received 8 weekly individualized counseling sessions of cognitive behavioral therapy
Study NCT02214329 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sensor-based exercise training
Description: Body-worn sensors are mounted on different body segments to acquire joint kinematic data and provide real-time joint feedback during exercise training.
Study NCT02214329 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: In-home balance training
Description: The control group performs similar exercise as intervention without sensors and with no visual feedback from sensors.
Study NCT02506868 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Darbepoetin alfa
Description: Weekly sc administration of darbepoetin alfa
Study NCT02506868 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Description: Weekly sc administration of darbepoetin alfa